SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-02-003764
Filing Date
2002-08-14
Accepted
2002-08-14 14:20:06
Documents
8
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 BIOGEN, INC. b43667bge10vq.htm 10-Q 207962
3 EX-3.1 BY-LAWS (AS AMENDED AND RESTATED) b43667bgexv3w1.txt EX-3.1 41509
4 EX-10.1 1985 NON-QUALIFIED STOCK OPTION PLAN b43667bgexv10w1.txt EX-10.1 43108
5 EX-10.2 AGREEMENT & AMENDMENT TO RIGHTS AGREEMENT b43667bgexv10w2.txt EX-10.2 4663
6 EX-99.1 CERTIFICATION PURSUANT TO SECTION 906 b43667bgexv99w1.txt EX-99.1 1954
7 COURTESY PDF b43667bge10vqxpdfy.pdf 10-Q 305701
8 GRAPHIC b43667bgxbox.gif GRAPHIC 1270
9 GRAPHIC b43667bgbox.gif GRAPHIC 1221
  Complete submission text file 0000950135-02-003764.txt   609895
Mailing Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142
Business Address 14 CAMBRIDGE CTR CAMBRIDGE MA 02142 6176792000
BIOGEN INC (Filer) CIK: 0000714655 (see all company filings)

IRS No.: 043002117 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12042 | Film No.: 02734572
SIC: 2836 Biological Products, (No Diagnostic Substances)